Update shared on 09 Dec 2025
Fair value Increased 0.33%Analysts have modestly raised their price target on CSN Mineração, reflecting improved expectations for revenue growth, slightly higher profit margins, and a lower projected future P/E multiple. Together, these factors support a fair value increase from approximately R$5.46 to about R$5.48 per share.
Valuation Changes
- Fair Value has risen slightly, moving from roughly R$5.46 to about R$5.48 per share.
- Discount Rate has increased marginally from about 20.99 percent to approximately 21.26 percent, implying a slightly higher required return.
- Revenue Growth expectations have improved significantly, shifting from a projected decline of around 9.32 percent to a modest expansion of about 0.89 percent.
- Net Profit Margin has edged higher, increasing from roughly 11.02 percent to about 11.73 percent.
- Future P/E has fallen significantly, decreasing from about 35.7x to roughly 24.6x, indicating a lower valuation multiple applied to future earnings.
Have other thoughts on CSN Mineração?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.